≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

LSIL lesion of the vulva

Endpoint Browser PheWeb

N14_VULVAL_LSIL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — N90.0
  • Hospital discharge: ICD-9 — 0781C
  • Cause of death: ICD-10 — N90.0
  • Cause of death: ICD-9 — 0781C

2 out of 7 registries used, show all original rules.

1086

4. Check minimum number of events

None

1086

5. Include endpoints

None

1086

6. Filter based on genotype QC (FinnGen only)

1086

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6816 6816 -
Only index persons 6423 6423 -
Unadjusted period prevalence (%)
Whole population 0.20 0.20 -
Only index persons 0.24 0.24 -
Median age at first event (years)
Whole population - 32.01 -
Only index persons - 31.60 -

-FinnGen-

Key figures

All Female Male
Number of individuals 1086 1086 -
Unadjusted period prevalence (%) 0.37 0.37 -
Median age at first event (years) 32.66 32.66 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
965
Matched controls
9650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N90.0
ICD-10 Finland
Mild vulvar dysplasia
+∞
323.0
379
*
0781C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]
+∞
323.0
587
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
24.9
183.0
266
145
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
201.5
164.5
167
10
8325
FHL
Coagulation, cryo or laser in anesthesia or operating room
235.5
139.9
141
7
ULA02
NOMESCO Finland
Kolposcopy
7.0
131.0
389
849
8411
FHL
Local change laser, coagulation, biopsy or removal
148.6
101.3
106
8
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.0
67.2
329
1097
LEB00
NOMESCO Finland
Biopsy of vagina
13.7
60.3
107
87
8326
FHL
Batch conization
29.9
49.8
67
24
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
4.3
46.6
194
535
A63.0
ICD-10 Finland
Anogenital (venereal) warts
6.6
43.7
119
202
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
17.9
42.6
67
40
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
71.9
42.4
48
7
N89.0
ICD-10 Finland
Mild vaginal dysplasia
28.2
41.2
56
21
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
3.3
40.3
242
896
D06BB04
ATC
podophyllotoxin; topical
4.9
35.7
124
281
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
6.9
35.4
92
146
D06BB10
ATC
imiquimod; topical
5.4
30.8
96
192
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
15.6
29.8
49
33
6221A
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI LEVIS]
51.8
29.5
35
7
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
32.9
29.2
38
12
N87.0
ICD-10 Finland
Mild cervical dysplasia
5.8
28.6
84
156
1390
FHL
Colposcopy
66.1
28.1
32
5
8111
FHL
Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)
38.6
24.0
30
8
LFC00
NOMESCO Finland
Partial excision of vulva
38.6
24.0
30
8
LDA10
NOMESCO Finland
Curettage of cervix uteri
3.7
23.7
109
320
6221B
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]
41.2
22.8
28
7
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
17.6
21.9
34
20
8113
FHL
Fractional scraping
3.5
21.2
103
315
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
3.2
17.3
94
313
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.8
17.1
435
3004
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
32.1
17.1
22
7
7950A
ICD-9 Finland
Nonspecific abnormal histological and immunological findings, Nonspecific abnormal Papanicolaou smear of cervix
35.7
16.7
21
6
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
13.0
16.7
29
23
J02AC01
ATC
fluconazole; systemic
1.8
16.5
561
4234
D07AD01
ATC
clobetasol; topical
2.2
15.9
186
955
8339
FHL
Other measure in this category
26.8
15.6
21
8
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
45.8
15.1
18
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
14.8
275
1691
P01AB01
ATC
metronidazole; oral, rectal
1.7
14.1
460
3364
N02AX02
ATC
tramadol; systemic, rectal
1.7
11.9
382
2735
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
3.9
11.9
49
132
G01AF04
ATC
miconazole; vaginal
2.5
11.7
97
420
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
4.7
11.1
37
82
G01AF01
ATC
metronidazole; vaginal
1.9
10.8
171
978
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
60.7
10.6
12
*
N87.1
ICD-10 Finland
Moderate cervical dysplasia
3.6
10.5
46
131
6350C
ICD-9 Finland
Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]
2.2
10.3
107
516
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.6
10.1
74
298
N90.4
ICD-10 Finland
Leukoplakia of vulva
11.4
10.1
18
16
6221C
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]
12.3
9.9
17
14
A10AA01
ATC
NA
3.8
9.8
40
108
A10AA02
ATC
NA
3.6
9.7
43
125
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.7
9.6
40
110
G01AA10
ATC
clindamycin; vaginal
1.7
9.5
236
1553
8112
FHL
Scraping the cervix
17.7
9.4
14
8
A63.8
ICD-10 Finland
Other specified predominantly sexually transmitted diseases
30.3
9.4
12
*
N03AX16
ATC
pregabalin; oral
1.7
9.3
234
1548
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.6
9.3
18
19
A02BC02
ATC
pantoprazole; systemic
1.5
9.1
614
5149
R4110
NOMESCO Finland
Physiotherapy
1.7
9.1
239
1601
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
9.0
443
3455
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.7
8.9
226
1496
127
Kela drug reimbursment
Transplant complication
6.0
8.8
23
39
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
50.5
8.7
10
*
WX002
NOMESCO Finland
Sedation and analgesia
1.7
8.5
172
1065
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
3.8
8.5
34
91
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
5.3
8.3
24
46
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
8.2
285
2040
J01FF01
ATC
clindamycin; systemic
1.6
8.2
260
1821
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
22.2
8.0
11
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
7.8
334
2501
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.8
7.8
49
181
ZXD05
NOMESCO Finland
Urgent procedure
1.5
7.7
283
2048
J01DA01
ATC
[U] cefalexin; systemic
1.5
7.5
617
5274
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
2.9
7.5
44
157
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
7.5
53
213
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.5
144
877
7020X
ICD-9 Finland
Other dermatoses, Actinic keratosis[DERMATOSES PRAECANCEROSAE ALIAE]
80.7
7.4
8
*
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
80.7
7.4
8
*
Z3231
NOMESCO Finland
Registered nurse
1.6
7.3
232
1617
J01MA02
ATC
ciprofloxacin; systemic
1.5
7.2
326
2460
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
4.1
7.2
26
64
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
4.6
7.1
23
51
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.4
7.1
20
38
Z2221
NOMESCO Finland
Medical doctor
1.5
7.1
269
1955
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
7.0
167
1080
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.0
98
537
G01AF02
ATC
clotrimazole; vaginal
2.3
6.9
65
300
8511
FHL
Cervical dilation and drainage with suction
2.2
6.9
70
336
TLC02
NOMESCO Finland
Simple extraction of IUD
2.1
6.9
73
359
UJF32
NOMESCO Finland
Coloscopy
1.6
6.9
210
1450
C03CA01
ATC
furosemide; systemic
1.6
6.9
166
1081
8513
FHL
Softening of cervix with abortifacient or laminars and associated surgical emptying of the uterus
2.5
6.8
52
218
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.3
6.8
60
271
R32
ICD-10 Finland
Unspecified urinary incontinence
3.2
6.8
33
105
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
40.3
6.8
8
*
ZX120
NOMESCO Finland
Intravenous
2.0
6.7
84
441
TQW40
NOMESCO Finland
Remowal of suture of skin
2.2
6.7
66
313
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.7
535
4504
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
6.6
239
1714
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.4
6.6
30
91
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
6.6
299
2255
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.8
6.5
40
149
N01BB02
ATC
lidocaine; parenteral
5.4
6.5
18
34
N06AB06
ATC
sertraline; oral
1.8
6.5
117
699
J01MA12
ATC
levofloxacin; systemic
1.7
6.5
144
914
L29.2
ICD-10 Finland
Pruritus vulvae
3.6
6.4
27
77
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.4
341
2652
H3603, E103
ICD-10 Finland
NA
4.9
6.4
19
39
A02BC05
ATC
esomeprazole; systemic
1.4
6.3
379
3012
A10AE05
ATC
insulin detemir; parenteral
2.5
6.3
46
190
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.3
221
1575
D07AC01
ATC
betamethasone; topical
1.5
6.3
299
2274
M01AH05
ATC
etoricoxib; oral
1.4
6.3
574
4922
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
+∞
6.3
6
*
TAC99
NOMESCO Finland
Other blockade for chronic pain
7.1
6.2
14
20
WX320
NOMESCO Finland
Spinalanesthesy
1.6
6.2
188
1292
A11CC03
ATC
alfacalcidol; systemic
4.0
6.2
23
59
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
6.1
135
855
J01DB01
ATC
cefalexin; oral
1.5
6.1
769
6989
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
6.1
82
443
M54.5
ICD-10 Finland
Low back pain
1.4
6.1
312
2404
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
8.7
6.1
12
14
TQW99
NOMESCO Finland
Other minor procedure on skin
2.5
6.1
44
181

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
153
207
8.44
109.40
3.0
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
43
58
7.68
30.29
2.6
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
599
4233
1.93
24.27
3.4
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
145
601
2.63
23.20
2.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
407
2638
1.87
20.55
2.2
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
226
1207
2.10
19.97
3.3
2.5
e6/l
4.7
4.8
0.02
135
587
(42870588) Differential panel, method unspecified - Blood
423
2992
1.68
14.53
7.2
5.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
217
1335
1.78
12.02
3.1
2.4
e6/l
1.2
1.2
0.04
126
715
(3007853) Bacteria identified in Skin by Aerobe culture
165
942
1.89
11.62
2.3
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
164
938
1.88
11.48
9.7
4.5
mmol/l
1.1
1.0
0.80
156
859
(3044640) Blood type and Crossmatch panel - Blood
382
2761
1.59
11.35
2.8
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
406
2979
1.58
11.30
5.5
3.3
e6/l
97.5
71.9
0.52
295
1997
(3002582) Erythrocytes [#/volume] in Urine
343
2423
1.61
11.19
4.7
2.8
e6/l
55.0
93.1
0.52
264
1810
(3022689) Creatine [Moles/volume] in Urine
14
16
8.85
11.13
1.6
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
478
3649
1.55
11.13
6.2
4.0
g/l
35.8
36.3
1.35
461
3406
(40758558) Short blood count panel - Blood
343
2449
1.59
10.59
9.7
6.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
113
594
2.01
10.11
1.3
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
314
2232
1.57
9.74
4.2
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
313
2224
1.57
9.72
4.4
2.7
e6/l
0.2
0.4
2.22
242
1637
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
445
3417
1.51
9.68
2.0
1.9
pmol/l
101.4
99.3
0.36
233
1710
(3020779) Urea [Moles/volume] in Serum or Plasma
105
547
2.02
9.63
12.5
6.5
mmol/l
8.6
8.2
0.33
100
524
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
41
140
3.00
9.43
8.0
4.7
iu/ml
527.0
173.1
0.73
11
14
(3033658) Prothrombin time (PT) actual/Normal
312
2242
1.55
9.13
5.3
3.2
%
97.3
98.2
0.30
303
2171
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
293
2082
1.56
9.00
2.5
2.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
485
3834
1.48
8.93
8.0
5.0
mmol/l
1.2
1.2
0.72
458
3500
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
166
1026
1.73
8.89
3.7
2.2
%
21.4
22.9
0.89
152
874
(3012095) Magnesium [Moles/volume] in Serum or Plasma
200
1302
1.66
8.82
4.3
2.9
mmol/l
0.8
0.8
0.67
193
1216
(40768797) Stomach Pathology biopsy report
208
1372
1.64
8.70
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
194
1259
1.66
8.65
3.3
2.1
umol/l
13.1
13.6
0.44
185
1158
(3004789) Transferrin [Mass/volume] in Serum or Plasma
179
1139
1.68
8.60
3.5
2.1
g/l
2.4
2.4
0.97
167
1059
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
102
551
1.94
8.44
2.1
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
225
1529
1.59
8.31
4.5
2.4
mosm/kgh2o
479.2
512.2
1.54
197
1309
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
48
192
2.57
8.24
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
127
744
1.80
8.16
5.5
4.5
u/l
228.5
256.1
1.08
122
707
(4035726)
136
814
1.77
8.13
1.5
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
643
5431
1.45
8.05
12.0
8.6
e9/l
3.9
3.9
0.04
579
4789
(3019198) Lymphocytes [#/volume] in Blood
579
4797
1.44
8.03
8.0
5.5
e9/l
1.9
1.9
0.27
539
4278
(3001604) Monocytes [#/volume] in Blood
564
4665
1.43
7.80
7.9
5.5
e9/l
0.5
0.5
1.13
515
4080
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
28
5.42
7.74
2.7
2.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
564
4681
1.43
7.57
8.0
5.5
e9/l
0.0
0.0
0.01
516
4089
(3002256) Pathology report gross observation
186
1236
1.61
7.48
1.3
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
582
4867
1.42
7.43
8.3
5.7
e9/l
0.2
0.2
0.85
544
4321
(3019069) Monocytes/100 leukocytes in Blood
530
4360
1.42
7.42
8.2
5.8
%
8.2
8.1
0.29
500
4097
(3002030) Lymphocytes/100 leukocytes in Blood
543
4491
1.42
7.35
8.0
5.6
%
29.1
29.3
0.17
512
4195
(3026008) Bacteria identified in Urine by Culture
358
2748
1.45
7.30
3.5
2.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
135
831
1.71
7.30
15.8
18.0
inr
1.2
1.2
0.04
16
127
(3006504) Eosinophils/100 leukocytes in Blood
527
4340
1.42
7.28
7.9
5.5
%
2.9
2.7
0.91
495
4049
(3021960) Folate [Moles/volume] in Serum or Plasma
258
1869
1.50
7.02
1.6
1.5
nmol/l
23.6
22.0
0.37
234
1623
(3009508) Creatinine [Moles/volume] in Urine
316
2389
1.46
6.92
4.4
2.9
mmol/l
6.4
6.9
1.17
258
2034
(3013707) Erythrocyte sedimentation rate by Westergren method
795
7079
1.46
6.90
4.8
4.0
mm/h
12.2
11.2
1.21
756
6615
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
519
4291
1.40
6.87
8.8
5.7
mmol/l
1.2
1.2
1.32
476
3618
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
361
2802
1.43
6.85
2.8
2.3
u/l
53.8
56.3
0.68
345
2592
(3000034) Microalbumin [Mass/volume] in Urine
20
53
3.83
6.83
3.3
3.1
mg/l
80.1
9.5
—
10
31
(3022096) Basophils/100 leukocytes in Blood
508
4189
1.40
6.81
8.1
5.6
%
0.7
0.7
0.27
480
3905
(3018010) Neutrophils/100 leukocytes in Blood
533
4441
1.39
6.67
7.9
5.4
%
56.3
56.6
0.17
505
4164
(3012516) Albumin [Mass/volume] in Urine
294
2213
1.45
6.53
4.3
3.0
mg/l
57.5
351.4
2.39
180
1263
(3042936) Bacteria identified in Isolate by Culture
167
1118
1.58
6.48
2.7
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
154
2.52
6.41
1.7
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
155
1023
1.60
6.38
1.7
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
303
2309
1.43
6.26
5.3
3.7
mg/mmol
11.3
7.0
0.67
192
1324
(3003327) Ova and parasites identified in Stool by Light microscopy
69
362
1.97
6.25
1.4
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
169
1146
1.56
6.19
1.9
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
391
3121
1.40
6.19
3.9
2.8
u/l
34.1
29.9
0.54
377
2986
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
120
752
1.67
6.07
2.6
3.4
pmol/l
4.3
4.5
1.09
103
669
(3000570) Elastase.pancreatic [Mass/mass] in Stool
55
269
2.10
6.03
1.5
1.4
ug/g
323.4
312.1
0.14
35
151
(3042733) HLA Ab [Presence] in Serum
10
16
6.30
5.96
6.0
4.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
256
1910
1.45
5.89
2.9
2.7
ng/l
966.7
821.1
0.32
220
1600
(3037467) Urinalysis macro (dipstick) panel - Urine
709
6260
1.38
5.88
5.5
4.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
219
1586
1.48
5.88
2.7
2.6
mmol/l
2.4
2.4
0.02
180
1409
(3013826) Glucose [Moles/volume] in Serum or Plasma
573
4892
1.36
5.88
5.9
4.1
mmol/l
6.7
6.5
1.00
545
4547
(3023368) Bacteria identified in Blood by Culture
252
1876
1.45
5.86
5.1
3.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
54
266
2.08
5.82
2.9
2.1
g/l
1.4
1.5
0.52
47
236
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
549
4667
1.36
5.73
7.1
5.5
umol/l
9.0
9.9
2.58
539
4425
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
500
4190
1.36
5.73
2.9
2.2
nmol/l
78.2
78.0
0.07
458
3839
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
151
1021
1.56
5.59
1.8
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
34
141
2.46
5.50
1.6
1.3
u/ml
110.6
123.7
—
5
29
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
160
2.36
5.47
1.5
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
77
439
1.81
5.44
1.8
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
146
988
1.55
5.38
2.9
2.3
umol/l
5.3
5.9
0.32
127
847
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
43
3.76
5.38
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
275
2.01
5.35
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
58
3.32
5.32
1.8
2.7
e6/l
662.7
693.5
—
6
24
(3005719) IgG [Mass/volume] in Serum or Plasma
109
690
1.64
5.31
3.1
3.0
g/l
9.8
10.3
0.58
103
643
(3007164) IgA [Mass/volume] in Serum or Plasma
263
2012
1.41
5.19
1.5
1.5
g/l
2.1
2.2
0.37
157
1266
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
200
1462
1.45
5.07
3.9
3.4
ng/l
101.2
327.6
2.07
123
945
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
275
2130
1.39
5.03
2.3
2.1
mg/l
3.1
2.9
0.45
252
1821
(3021601) Nitrite [Presence] in Urine by Test strip
528
4520
1.33
5.00
6.0
4.8
estimate
0.0
0.0
0.50
77
845
(3000991) Gas panel - Venous blood
89
544
1.69
4.96
10.2
7.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
112
727
1.60
4.94
3.3
2.7
%
1.8
1.8
0.03
102
646
(3000850) Epithelial cells [#/volume] in Urine
225
1689
1.42
4.93
4.1
2.3
e6/l
6.1
8.1
1.39
196
1491
(3048689) Calprotectin [Mass/mass] in Stool
178
1279
1.47
4.93
1.9
2.2
ug/g
174.4
101.3
0.92
141
1008
(3009261) Glucose [Presence] in Urine by Test strip
532
4567
1.32
4.91
4.4
3.6
estimate
0.0
0.0
1.06
73
831
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
780
7083
1.36
4.85
9.6
6.8
u/l
74.6
75.9
0.56
740
6691
(3037522) Nuclear Ab [Titer] in Serum
204
1512
1.43
4.79
1.5
1.3
titre
545.7
589.1
0.19
53
323
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
7
11.50
4.79
5.6
4.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
989
9384
1.60
4.73
17.7
11.7
mg/l
19.0
19.4
0.19
814
7239
(3011397) Hemoglobin [Presence] in Urine by Test strip
264
2050
1.38
4.73
4.4
3.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
102
655
1.62
4.71
1.4
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
86
529
1.68
4.69
2.3
2.7
ng/l
202.6
145.2
0.50
75
473
(3045414) Leukocytes [Presence] in Urine
71
415
1.76
4.65
2.4
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
34
153
2.26
4.63
1.4
1.2
u/ml
336.3
286.5
0.41
27
95
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
154
1091
1.48
4.57
1.7
1.6
%
1.4
1.3
0.28
131
981
(3019309) Folate [Moles/volume] in Red Blood Cells
189
1396
1.43
4.51
1.8
1.7
nmol/l
1218.9
1202.8
0.08
160
1059
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
104
680
1.59
4.46
5.4
3.1
ng/l
104.4
73.8
1.56
94
606
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
36
169
2.17
4.45
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
522
4517
1.30
4.36
3.4
2.8
ug/l
98.0
81.7
1.14
503
4251
(3014765) Yersinia sp identified in Stool by Organism specific culture
56
312
1.84
4.31
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
90
575
1.62
4.26
1.5
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
309
2500
1.33
4.18
1.7
1.6
mmol/l
1.4
1.4
0.28
271
2161
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
27
4.11
4.17
1.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
56
316
1.81
4.15
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
518
4497
1.29
4.15
4.4
3.5
estimate
0.0
0.0
0.00
73
846
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
55
309
1.82
4.13
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
957
9062
1.47
4.11
5.9
5.2
mu/l
1.8
2.1
0.90
899
8512
(3045424) Erythrocytes [Presence] in Urine
31
142
2.22
4.08
2.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
490
4231
1.29
4.06
4.3
3.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
65
387
1.72
4.03
1.6
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
119
822
1.50
4.01
2.3
2.2
u/l
32.1
37.5
0.77
101
690
(3023520) Reticulocytes [#/volume] in Blood
82
521
1.62
3.98
2.7
2.8
e9/l
68.3
74.5
0.74
57
386
(3037121) Protein [Mass/volume] in Urine
47
255
1.88
3.95
2.4
3.0
g/l
0.3
0.3
0.12
20
77
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
110
750
1.52
3.94
2.3
2.2
ml/min/173m2
62.1
73.1
1.61
41
293
(3052851) Hemolysis interference index of Serum or Plasma
46
249
1.88
3.89
6.4
2.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
68
416
1.68
3.83
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
107
730
1.52
3.82
1.7
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
65
393
1.70
3.82
2.9
3.1
mmol/l
1.5
1.8
0.29
49
303
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
29
3.82
3.81
1.0
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
92
609
1.56
3.77
1.5
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
67
410
1.68
3.77
2.9
3.1
ph
7.4
7.4
—
9
60
(3035320) C reactive protein [Mass/volume] in Body fluid
16
55
2.94
3.74
2.8
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
89
586
1.57
3.74
2.9
2.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
22
90
2.47
3.73
1.9
1.8
mg/l
20.6
19.0
0.07
11
30
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
84
2.53
3.73
1.1
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
373
3139
1.29
3.70
4.0
3.4
mmol/l
2.4
2.4
0.30
331
2811
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
38
197
1.96
3.66
1.2
1.3
—
9.3
—
0
5
(3018418) pH of Serum or Plasma
312
2571
1.30
3.62
6.7
3.5
ph
7.4
7.4
0.45
42
497
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
294
2406
1.30
3.59
1.4
1.3
u/ml
2.3
1.7
0.20
86
661
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
68
2.67
3.57
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
68
2.67
3.57
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
27
124
2.21
3.56
1.4
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
19
74
2.60
3.56
6.7
2.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
93
628
1.53
3.50
6.2
3.0
mmol/l
2.1
2.2
0.11
78
504
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
93
2.39
3.50
2.3
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
51
296
1.76
3.48
2.6
3.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
938
8902
1.39
3.48
15.3
10.4
ml/min/173m2
84.3
84.8
0.27
804
7345
(3018677) aPTT in Platelet poor plasma by Coagulation assay
153
1140
1.40
3.47
3.0
1.9
s
28.4
29.4
1.47
148
1104
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
44
245
1.83
3.44
1.3
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
305
2522
1.29
3.43
2.2
2.1
u/l
120.2
160.4
0.81
294
2387
(3000494) Fungus identified in Specimen by Culture
144
1064
1.41
3.42
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
30
147
2.07
3.38
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
30
147
2.07
3.38
1.5
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
9
18
5.03
3.37
1.0
1.0
—
—
—
0
0
(3013512) EKG study
286
2353
1.29
3.33
3.7
3.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
207
1631
1.33
3.29
1.8
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
109
2.23
3.27
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
127
927
1.42
3.24
1.9
2.0
nmol/l
388.1
371.5
0.39
119
860
(3014111) Lactate [Moles/volume] in Serum or Plasma
88
604
1.50
3.09
8.1
5.9
mmol/l
1.0
1.3
3.69
82
580
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
139
2.04
3.08
1.1
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
38
210
1.84
3.07
2.7
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
34
3.26
3.06
1.9
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
77
515
1.53
3.06
5.1
2.5
kpa
4.8
4.6
0.31
71
496
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
711
6546
1.25
3.03
3.3
2.9
u/l
42.9
39.2
0.64
683
6205
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
172
1340
1.34
2.95
1.6
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
177
1.89
2.93
1.9
2.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1029
9990
1.57
2.84
12.7
9.5
u/l
23.7
24.0
0.24
1008
9727
(3011412) CD3 cells [#/volume] in Blood
18
77
2.36
2.83
2.1
2.6
e9/l
1.4
1.1
0.25
11
48
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
65
2.48
2.80
1.1
1.2
titre
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
6
8.36
2.75
4.8
6.7
mmol/l
4.0
6.9
—
5
6
(3021589) Normoblasts [#/volume] in Blood
465
4121
1.22
2.73
11.5
8.3
e9/l
0.0
0.0
0.14
405
3379
(3015171) Extractable nuclear Ab [Units/volume] in Serum
69
463
1.52
2.72
1.4
1.3
u/ml
0.3
1.0
—
10
43
(3024932) HLA-DR beta [Type]
8
19
4.23
2.68
1.1
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
51
321
1.62
2.65
3.5
1.9
g/l
0.2
0.2
1.23
51
303
(3022145) Colonoscopy Study observation
135
1034
1.35
2.60
1.2
1.3
—
—
—
0
0
(4015189)
7
15
4.69
2.60
1.3
4.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
851
8050
1.26
2.59
5.0
4.4
pmol/l
14.7
14.5
1.58
798
7528
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
247
2054
1.26
2.59
1.4
1.3
iu/ml
25.8
28.6
0.19
67
667
(40768446) Kidney Pathology biopsy report
9
25
3.62
2.57
2.3
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
114
2.04
2.57
3.1
2.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
56
364
1.57
2.56
2.8
2.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
30
164
1.85
2.55
3.6
2.7
mmol/l
24.5
25.4
0.74
25
146
(3020961) Endomysium IgA Ab [Titer] in Serum
78
545
1.46
2.55
1.2
1.1
—
164.6
—
0
12
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
28
150
1.89
2.53
1.4
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
33
3.05
2.53
1.1
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
33
3.05
2.53
1.1
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
65
439
1.51
2.51
1.8
1.9
u/l
2282.6
3435.9
0.20
22
162
(3032080) INR in Blood by Coagulation assay
347
3009
1.23
2.47
8.6
7.0
inr
1.2
1.1
0.28
90
943
(36660697) Celiac disease serology panel - Serum
112
841
1.37
2.46
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
57
2.48
2.45
2.2
2.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
70
2.30
2.42
1.1
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
231
1921
1.26
2.41
4.6
3.9
kg/l
1.0
1.0
0.62
34
274
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
43
267
1.64
2.38
1.4
1.6
—
160.0
—
0
12
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
151
1193
1.31
2.36
2.0
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
46
2.63
2.36
8.2
2.7
—
—
—
0
0
(4034850)
45
285
1.60
2.31
10.8
7.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
267
2268
1.24
2.30
2.0
1.7
mg/l
1.0
0.8
0.51
202
1707
(3026493) Urate [Moles/volume] in Serum or Plasma
261
2213
1.24
2.29
3.0
2.2
umol/l
2906.3
4194.2
0.29
231
1948
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
51
336
1.54
2.23
3.6
1.9
g/l
1.1
1.2
2.16
51
315
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
60
2.35
2.22
1.8
2.1
%
10.3
12.7
—
8
28
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
133
1042
1.31
2.22
4.4
4.1
%
32.3
33.1
0.38
97
730
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
46
297
1.57
2.20
1.5
1.4
u/l
36.5
29.9
0.64
40
246
(3019550) Sodium [Moles/volume] in Serum or Plasma
979
9474
1.34
2.18
18.7
12.3
mmol/l
139.6
139.7
0.95
966
9257
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
346
3034
1.21
2.16
3.7
3.0
ng/l
22.7
40.9
0.65
201
1705
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
938
9030
1.28
2.13
4.2
3.7
mmol/l
1.3
1.2
1.65
883
8456
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
24
130
1.87
2.13
1.3
1.4
mmol/l
6.8
7.2
0.30
18
95
(3012441) Differential panel - Pleural fluid
11
43
2.57
2.10
1.7
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
5
10
5.02
2.07
1.0
1.0
nmol/l
5.7
5.7
—
5
10
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
108
830
1.33
2.07
3.7
3.7
ug/l
3.5
15.8
1.46
86
649
(3023103) Potassium [Moles/volume] in Serum or Plasma
980
9499
1.32
2.04
19.3
12.4
mmol/l
3.9
3.9
1.14
966
9257
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
51
739
0.67
2.03
1.4
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
162
1.75
2.03
1.3
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
101
775
1.33
1.96
7.4
7.3
mmol/l
1.3
1.3
0.05
83
611
(40768806) Pleura Pathology biopsy report
11
45
2.46
1.93
1.7
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
242
2071
1.22
1.92
1.6
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
309
1.51
1.88
1.3
1.3
u/ml
10.2
10.1
—
6
61
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
58
411
1.43
1.83
2.3
2.2
u/l
45.3
39.3
1.16
53
373
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
12
4.18
1.82
1.2
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
879
8438
1.22
1.81
6.5
4.9
mmol/mol
39.9
38.7
3.00
828
7933
(3000330) Specific gravity of Urine by Test strip
56
396
1.44
1.79
4.1
3.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
71
524
1.38
1.79
1.4
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
335
3745
0.85
1.76
2.8
2.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
74
2.04
1.75
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
266
1.52
1.73
1.1
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
133
1.75
1.71
1.1
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
17
90
1.90
1.65
1.2
1.2
u/l
57.0
55.2
0.07
12
64
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
534
1.35
1.61
2.2
2.2
ug/l
4.4
5.0
0.21
66
468
(3020630) Protein [Mass/volume] in Serum or Plasma
79
605
1.33
1.60
1.7
2.6
g/l
65.0
67.7
1.92
71
565
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
810
1.29
1.59
1.9
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
57
2.12
1.55
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
64
2.04
1.54
1.7
2.2
u/field
3.0
2.1
—
8
34
(40761511) CBC panel - Blood by Automated count
1010
9880
1.32
1.54
15.0
10.9
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
15
3.34
1.52
2.6
2.3
umol/l
23.5
24.5
—
5
15
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
27
2.60
1.51
1.3
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
27
2.60
1.51
1.3
2.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
27
2.60
1.51
1.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
27
2.60
1.51
1.0
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
27
2.60
1.51
1.3
2.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
21
2.87
1.50
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
81
1031
0.77
1.50
1.7
1.7
—
—
—
0
0
(4062490)
19
109
1.76
1.47
1.5
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
16
3.13
1.44
1.6
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
19
110
1.74
1.43
1.1
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
312
1.43
1.43
1.9
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
39
2.32
1.43
1.6
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
23
141
1.64
1.42
1.1
1.3
nmol/l
0.4
0.6
2.85
23
135
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
101
814
1.27
1.42
1.9
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
197
1.54
1.41
1.5
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
33
222
1.50
1.40
1.3
1.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
23
142
1.63
1.39
1.1
1.3
nmol/l
—
0.4
—
0
5
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
142
1.63
1.39
1.0
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
26
166
1.58
1.38
1.9
1.9
g/l
121.7
131.4
1.44
20
120
(3006462) Nitrate [Presence] in Urine
9
41
2.20
1.37
2.9
3.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
23
2.62
1.37
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
385
3521
1.14
1.34
4.5
3.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
10
47
2.14
1.34
2.9
2.2
ug/l
32.8
194.6
—
10
40
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
42
2.15
1.34
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
87
695
1.27
1.32
2.0
2.6
e9/l
4.3
4.0
0.43
74
566
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
129
1.64
1.30
1.9
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
963
9395
1.22
1.30
4.8
4.1
mmol/l
4.9
4.9
0.62
917
8885
(44816559) Phosphatidylethanol [Mass/volume] in Blood
24
153
1.58
1.29
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
113
934
1.23
1.29
1.5
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
34
2.36
1.29
1.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
34
2.36
1.29
1.0
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
10
48
2.09
1.28
2.3
3.0
e9/l
0.2
0.1
—
10
48
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
159
0.50
1.25
2.4
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
25
2.41
1.24
2.3
3.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
28
188
1.50
1.22
2.1
2.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
164
1.54
1.21
3.0
2.5
ug/min
169.3
118.6
0.17
15
107
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
974
9524
1.22
1.21
5.2
4.5
mmol/l
2.9
2.9
0.75
915
8948
(3017704) Immunofixation for Urine
0
34
0.00
1.16
0.0
1.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
1057
10446
1.44
1.16
25.3
17.5
fl
91.1
90.8
1.14
1050
10342
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.3
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.6
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.3
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.3
1.8
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
134
1.58
1.15
1.1
1.3
nmol/l
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
226
2012
1.16
1.14
1.4
1.3
u/ml
5.4
10.2
0.96
88
828
(3035941) MCH [Entitic mass]
1057
10448
1.44
1.13
25.2
17.5
pg
30.2
30.1
0.99
1050
10343
(3026361) Erythrocytes [#/volume] in Blood
1057
10448
1.44
1.13
25.4
17.5
e12/l
4.4
4.4
1.35
1038
10229
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
225
1.44
1.13
2.4
1.4
e6/l
8.6
13.7
0.37
24
169
(3010813) Leukocytes [#/volume] in Blood
1057
10449
1.43
1.12
25.4
17.6
e9/l
6.6
6.6
0.44
1040
10230
(1616796) Gas panel - Central venous blood
22
143
1.55
1.12
7.7
2.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
96
1149
0.82
1.08
1.3
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
32
2.19
1.08
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
32
2.19
1.08
1.1
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1057
10453
1.42
1.07
25.5
17.6
g/l
132.4
133.0
0.97
1051
10350
(3007461) Platelets [#/volume] in Blood
1056
10442
1.41
1.06
25.5
17.6
e9/l
267.9
267.6
0.05
1042
10249
(3011648) Oxygen content in Venous blood
10
52
1.93
1.06
3.0
2.3
%
10.4
10.8
—
10
52
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.3
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
86
709
1.23
1.04
1.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
26
179
1.46
1.03
4.7
4.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
138
1.53
1.03
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
34
2.07
1.03
1.4
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
180
1.46
1.01
5.6
2.8
u/ml
0.3
0.4
0.53
17
98
(4211845)
9
48
1.88
1.00
2.9
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
25
172
1.46
1.00
4.8
1.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
49
379
1.31
1.00
1.6
1.6
mu/l
314.5
315.3
0.01
42
335
(3036489) Thrombin time
45
344
1.32
0.99
3.3
1.7
s
21.1
20.6
0.39
39
291
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
713
6853
1.12
0.99
3.4
3.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
61
1.81
0.98
1.1
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
23
2.18
0.98
2.2
3.6
%
56.1
49.9
—
5
23
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
15
92
1.64
0.97
1.4
1.2
—
63.9
—
0
8
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
23
157
1.48
0.96
1.2
1.1
%
132.3
123.9
0.60
23
147
(4306422)
23
157
1.48
0.96
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
40
303
1.33
0.95
2.1
2.0
iu/l
2.8
4.8
2.05
18
124
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
9
51
1.77
0.94
1.1
1.0
%
88.8
93.5
—
9
44
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
57
454
1.27
0.94
2.4
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
85
1.66
0.94
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
37
1.90
0.94
1.3
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
27
2.23
0.93
1.0
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
55
1.83
0.92
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
270
1.34
0.91
1.3
2.0
g/l
3.2
3.1
0.30
31
221
(3017446) Testosterone [Moles/volume] in Serum or Plasma
13
78
1.67
0.91
1.5
1.3
nmol/l
1.1
1.9
0.79
13
65
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
78
1.67
0.91
1.1
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
6
28
2.15
0.91
1.0
1.3
pmol/l
188.5
360.0
—
6
22
(3029937) Albumin [Presence] in Urine by Test strip
259
2368
1.12
0.88
5.1
3.9
estimate
0.0
0.0
0.80
78
844
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
25
346
0.72
0.88
2.0
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
111
1.54
0.88
1.9
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
111
1.54
0.88
1.6
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
56
1.79
0.88
1.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
21
144
1.47
0.87
1.1
1.3
—
43.4
—
0
10
(3019225) pH of Specimen
100
854
1.19
0.87
3.4
3.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
953
9346
1.16
0.87
4.7
4.1
mmol/l
1.6
1.6
1.19
896
8796
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
112
1.53
0.85
1.6
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
112
1.53
0.85
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
112
1.53
0.85
1.6
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
31
1.94
0.84
1.8
2.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
6
31
1.94
0.84
1.8
2.3
%
7.2
6.9
—
6
31
(3001019) Free T4 and TSH panel - Serum or Plasma
72
861
0.82
0.84
1.6
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
42
328
1.29
0.83
1.7
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
14
89
1.58
0.81
1.4
1.1
—
42.7
—
0
6
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
14
89
1.58
0.81
1.4
1.2
—
74.8
—
0
9
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
285
1.31
0.81
1.3
2.0
g/l
7.6
7.5
0.11
31
230
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
285
1.31
0.81
1.3
2.0
g/l
3.4
3.7
0.93
31
217
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
285
1.31
0.81
1.3
2.0
—
—
—
0
0
(3044889) 12 lead EKG panel
664
6397
1.10
0.79
3.9
3.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
24
0.00
0.79
0.0
1.1
—
84.3
—
0
6
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
66
1.67
0.79
4.4
3.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
131
1.46
0.78
1.6
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
67
1.65
0.75
1.2
1.8
—
—
—
0
0
(4024509)
11
67
1.65
0.75
1.5
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
927
9101
1.13
0.70
4.8
4.1
mmol/l
5.9
5.7
2.08
869
8486
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
68
575
1.19
0.69
1.1
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
85
1.54
0.69
2.2
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
27
1.86
0.68
2.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
170
1.36
0.68
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
43
348
1.25
0.67
12.4
10.2
—
—
—
0
0
(4094501)
30
232
1.30
0.66
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
95
1.48
0.64
2.4
2.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
20
146
1.38
0.64
1.6
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
16
112
1.43
0.63
9.5
2.2
%
64.9
62.2
0.22
16
112
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
15
104
1.45
0.62
1.4
1.7
%
62.6
51.0
—
10
62
(40761535) Cells panel - Urine sediment
78
676
1.17
0.62
4.1
3.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
147
1.37
0.62
2.7
2.2
%
15.6
16.4
0.53
14
71
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
63
1.59
0.62
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
63
1.59
0.62
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
63
1.59
0.62
1.2
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
50
1.60
0.61
1.5
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
165
1.34
0.60
1.3
1.1
u/ml
4.0
1.7
—
5
50
(3023323) Follitropin [Units/volume] in Serum or Plasma
112
1001
1.13
0.59
1.3
1.3
iu/l
32.5
33.6
0.12
90
872
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
114
1.41
0.59
1.7
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
16
114
1.41
0.59
1.1
1.1
%
96.3
100.8
0.27
16
109
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
54
1.48
0.57
1.3
1.8
ug/l
34.2
25.0
—
8
54
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
81
1.49
0.57
1.8
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
115
1.40
0.56
1.7
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
115
1.40
0.56
1.7
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
73
1.51
0.56
1.8
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
203
1.29
0.56
2.5
1.5
—
—
—
0
0
(4010399)
76
664
1.16
0.56
1.4
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
65
1.54
0.55
1.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
65
1.54
0.55
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
198
1835
1.10
0.55
1.6
1.6
pmol/l
498.9
28207200.9
1.76
175
1567
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
31
383
0.80
0.54
1.3
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
126
0.63
0.54
1.3
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
118
1.36
0.50
1.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
50
427
1.18
0.50
7.3
5.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
127
1.34
0.49
1.8
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
45
1.56
0.49
1.0
1.3
—
—
—
0
0
(4268621)
15
110
1.37
0.49
2.3
2.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
31
253
1.23
0.48
1.3
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
154
1.30
0.48
12.6
3.1
mmol/l
3.2
2.7
0.22
13
105
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
49
1.43
0.46
5.0
3.0
u/ml
474.9
1088.7
—
7
49
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
34
283
1.21
0.45
1.2
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
192
1.26
0.45
3.4
3.4
e9/l
4.0
4.2
0.22
24
192
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
37
311
1.20
0.45
1.4
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
85
764
1.12
0.44
2.4
2.4
au/ml
7.9
22.5
—
5
56
(3037756) Immunofixation for Serum or Plasma
18
139
1.30
0.44
1.1
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
78
1.41
0.43
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
78
1.41
0.43
1.3
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
78
1.41
0.43
1.7
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
78
1.41
0.43
1.3
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
31
1.62
0.43
1.0
1.1
%
—
8.0
—
0
5
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
285
1.20
0.43
2.2
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
32
267
1.20
0.42
2.9
2.8
u/ml
49.5
676.3
0.67
26
233
(44813793)
12
87
1.38
0.42
1.1
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
140
1.29
0.42
5.8
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
176
1.26
0.42
1.7
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
176
1.26
0.42
1.4
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
15
0.00
0.41
0.0
7.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
79
1.40
0.41
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
79
1.40
0.41
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
79
1.40
0.41
1.3
1.1
—
—
—
0
0
(44806420)
0
17
0.00
0.40
0.0
2.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
17
0.00
0.40
0.0
3.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
17
0.00
0.40
0.0
1.2
—
318.9
—
0
11
(3041096) Erythrocytes [Presence] in Urine by Automated
267
2540
1.07
0.40
3.8
3.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
38
442
0.85
0.39
2.0
1.8
mg/l
3.8
2.8
0.22
25
305
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
46
400
1.16
0.39
1.3
1.3
miu/ml
169.3
241.1
0.71
20
203
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
1.4
2.1
mg/l
7.8
9.0
—
5
28
(3025159) Blasts/100 leukocytes in Blood
75
675
1.12
0.39
5.1
4.1
%
0.0
1.2
0.85
19
147
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
196
1.23
0.39
3.6
3.8
%
57.4
58.1
0.10
24
196
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
66
1.37
0.38
1.6
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
810
8226
0.94
0.38
22.6
14.9
g/l
330.7
331.0
0.42
803
8167
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
289
1.18
0.38
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
289
1.18
0.38
1.7
1.6
iu/ml
0.0
0.1
0.71
11
41
(3021440) Promyelocytes/100 leukocytes in Blood
79
715
1.11
0.38
4.9
4.1
%
0.0
0.1
1.09
23
181
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
170
1.24
0.37
1.7
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
42
1.43
0.35
1.5
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
144
1.25
0.35
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
43
1.40
0.35
1.0
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
218
1.20
0.34
1.5
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
218
2290
0.94
0.34
5.4
4.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
252
2408
1.06
0.34
1.4
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
45
1.34
0.33
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
54
482
1.13
0.33
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
17
136
1.25
0.33
1.3
1.3
mmol/l
49.0
65.5
1.52
17
109
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
127
1.26
0.33
1.3
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
46
1.31
0.33
2.5
2.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
88
0.68
0.33
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
83
1.33
0.32
2.1
2.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
83
1.33
0.32
1.5
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
128
1.25
0.32
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
47
419
1.13
0.30
1.7
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
81
745
1.09
0.30
1.4
1.3
u/ml
193.8
176.1
0.09
76
698
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
54
1.30
0.30
2.3
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
84
1.31
0.30
1.0
1.1
—
—
—
0
0
(4281824)
11
141
0.78
0.29
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
57
1.23
0.29
1.3
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
167
1.20
0.28
1.3
1.2
u/ml
2.1
4.2
—
10
57
(3023410) Appearance of Cerebral spinal fluid
14
112
1.25
0.28
3.1
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
76
1.32
0.28
1.0
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
62
1.29
0.28
2.1
1.5
nmol/l
1.4
1.4
—
8
56
(4146454)
8
64
1.25
0.27
2.0
2.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
11
139
0.79
0.27
1.0
1.1
iu/ml
96.6
3951.4
—
5
32
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
95
887
1.08
0.26
1.2
1.2
iu/ml
172.9
164.1
0.07
33
372
(40760888) Immunoglobulin light chains.free panel - Serum
18
150
1.20
0.26
1.2
4.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
87
810
1.08
0.26
3.5
2.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
86
1.28
0.26
1.7
2.0
pg
34.5
31.5
1.62
11
86
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
73
0.68
0.26
4.0
7.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
89
830
1.08
0.26
1.4
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
244
1.15
0.26
4.0
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
81
753
1.08
0.25
4.8
4.0
%
0.4
1.0
1.94
24
200
(3021788) Differential panel - Synovial fluid
19
160
1.19
0.25
1.7
1.7
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
73
1.23
0.25
5.2
1.9
ug/l
40.5
9.0
—
9
59
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
181
0.83
0.25
1.3
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
74
1.22
0.25
3.4
3.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
191
0.84
0.24
1.3
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
87
1.27
0.24
2.0
1.4
g/l
0.9
1.0
0.11
11
87
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
77
1.17
0.24
2.2
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
190
0.84
0.23
1.3
1.4
—
—
—
0
0
(4198724)
5
38
1.32
0.23
7.6
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
88
1.25
0.22
2.4
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
120
1139
1.06
0.22
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
79
1.27
0.22
1.4
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
41
1.22
0.22
1.6
1.8
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
10
124
0.80
0.21
1.0
1.0
—
0.2
—
0
26
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
8.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.5
—
35.7
—
0
10
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
3.8
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
5.8
—
0
10
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
6
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
198
0.86
0.20
1.3
1.4
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.2
—
0.5
—
0
7
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
14
0.00
0.20
0.0
7.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
57
613
0.93
0.20
1.6
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
108
1027
1.06
0.19
6.7
5.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
112
1067
1.06
0.19
1.8
1.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
90
1.22
0.19
2.4
2.2
mmol/l
4.2
3.9
1.08
11
90
(3035285) Chloride [Moles/volume] in Venous blood
11
90
1.22
0.19
2.4
2.2
mmol/l
103.5
105.8
1.14
11
90
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
90
1.22
0.19
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
58
1.21
0.18
1.3
1.9
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
58
1.21
0.18
2.3
1.7
—
1.2
—
0
7
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
110
1.18
0.17
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
110
1.18
0.17
1.9
1.5
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
7
63
1.11
0.17
15.6
11.1
mmol/l
0.8
0.7
—
7
55
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
70
1.14
0.16
1.8
1.6
nmol/l
14.4
19.2
—
8
65
(3020891) Body temperature
30
273
1.10
0.16
8.0
4.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
73
769
0.95
0.15
5.2
3.7
—
—
—
0
0
(4027681)
9
80
1.13
0.15
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
150
1.14
0.14
8.6
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
198
1.11
0.14
5.4
2.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
139
0.86
0.14
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
96
0.83
0.13
1.1
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
242
0.91
0.13
1.3
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
31
287
1.08
0.12
3.4
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
72
689
1.05
0.12
4.6
3.9
%
0.1
0.7
4.60
15
139
(3008898) HLA-B27 [Presence]
43
455
0.94
0.11
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
202
1.09
0.10
1.1
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
1.2
1.8
nmol/l
1.2
1.2
—
5
40
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
227
0.92
0.09
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
227
0.92
0.09
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
54
1.11
0.09
1.2
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
226
0.93
0.08
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
226
0.93
0.08
1.3
1.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
5
60
0.83
0.08
1.6
1.4
—
64.6
—
0
8
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
29
273
1.06
0.08
4.8
3.8
u/ml
18.6
28.7
0.91
29
264
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
33
313
1.06
0.07
3.8
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
71
0.84
0.07
2.7
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
75
1.07
0.07
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
101
0.89
0.06
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
25
264
0.95
0.06
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
111
0.90
0.06
1.1
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
178
1.07
0.05
4.5
3.6
mg/l
16.7
19.6
0.24
12
111
(3000764) Benzodiazepines [Presence] in Urine
33
316
1.05
0.05
3.7
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
33
316
1.05
0.05
3.7
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
149
1.07
0.05
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
33
317
1.04
0.05
3.7
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
91
1.10
0.04
1.8
2.0
%
89.5
90.3
—
10
91
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
101
1.09
0.04
2.0
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
180
0.94
0.04
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
13
121
1.08
0.03
1.5
1.7
ug/l
4.3
4.7
—
8
97
(3002385) Erythrocyte distribution width [Ratio]
800
8017
0.99
0.03
22.2
14.1
%
13.7
13.6
0.20
790
7867
(3009542) Hematocrit [Volume Fraction] of Blood
873
8743
0.99
0.02
18.7
12.6
%
38.8
39.4
1.45
690
6807
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
17
177
0.96
0.01
1.1
1.0
u/ml
6.5
2.3
—
9
90
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
12
114
1.05
0.00
2.7
5.1
u/ml
9.7
51.1
—
5
32
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
176
1.02
0.00
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
132
0.98
0.00
1.7
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
188
1.01
0.00
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
129
1.01
0.00
1.5
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
189
1.01
0.00
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
37
367
1.01
0.00
1.2
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
79
0.89
0.00
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
88
0.91
0.00
1.3
1.2
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
205.4
—
0
8
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
56
0.89
0.00
1.4
1.2
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
70.6
—
0
6
(44790048)
8
87
0.92
0.00
2.5
1.4
—
—
—
0
0
(44790047)
8
87
0.92
0.00
2.5
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
7.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
13.1
—
0
7
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806118)
8
87
0.92
0.00
2.5
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
8.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
85
0.94
0.00
4.4
2.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
93
0.97
0.00
1.6
1.5
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
34.8
—
0
6
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
5
0.00
0.00
0.0
1.8
—
601.4
—
0
5
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
110
1.00
0.00
1.0
1.1
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
4249.4
—
0
5
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
70
1.00
0.00
1.6
1.3
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
111.0
—
0
5
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
83
0.96
0.00
1.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
359.3
—
0
6
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(44790049)
8
87
0.92
0.00
2.5
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
65
0.92
0.00
1.2
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
6
64
0.94
0.00
1.0
1.1
—
55.6
—
0
7
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_VULVAL_LSIL and mortality.

Females

Parameter HR [95% CI] p-value
N14_VULVAL_LSIL 0.98 [0.83, 1.16] 0.81
Birth year 0.998 [0.99, 1.01] 0.701

During the follow-up period (1.1.1998 — 31.12.2019), 201 out of 1884 females with N14_VULVAL_LSIL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_VULVAL_LSIL.

N-year risk Females Males
1 0.081% No data
5 0.557% No data
10 1.448% No data
15 2.86% No data
20 5.428% No data

Relationships between endpoints

↥

Index endpoint: N14_VULVAL_LSIL – LSIL lesion of the vulva

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data